Benton CB, Takahashi K, Bose P, Wang F, H-C C, Zheng X, Zhang J, Wang X, Su X, Montalban-Bravo G, Issa GC, Daver N, Jabbour EJ, DiNardo CD, Bueso-Ramos CE, Patel K, Kornblau SM, Konopleva M, Borthakur G, Kadia TM, Cortes JE, Ravandi F, Andreeff M , Garcia-Manero G, Futreal A, Kantarjian H
It is studied in research laboratories for its role in peptide receptor activity and endocrine-related mechanisms
Thank you for the work that you do in womens health
Whether those ingredient-level effects translate to meaningful outcomes in this specific formula, at these specific doses, for any given person - that depends on factors the available research can't predict
[3] Sermorelin was originally approved in the 1990s for GH deficiency but was later discontinued as a commercial drug for business reasons (not due to safety or efficacy concerns)